Type III Neuregulin-1 Is Required for Normal Sensorimotor Gating, Memory-Related Behaviors, and Corticostriatal Circuit Components

The mouse brain in stereotaxic coordinates

Konsman, J. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00088-x · Cited by 16,796

The Mouse Brain in Stereotaxic Coordinates

Paxinos, G. (2001) · Cited by 12,859

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020

The hippocampal-VTA loop: controlling the entry of information into long-term memory

Lisman, J. E., & Grace, A. A. (2005) · Neuron · doi:10.1016/j.neuron.2005.05.002 · Cited by 1,983

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

BRAFF, D. L., Geyer, M. A., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100810 · Cited by 1,701

Neuregulin 1 and Susceptibility to Schizophrenia

Stefánsson, H., Pétursson, H., Sigurðsson, E., Steinthórsdóttir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342734 · Cited by 1,671

Meta-analysis of regional brain volumes in schizophrenia

Wright, I. C., Rabe-Hesketh, S., Woodruff, P. W. R., David, A. S., Murray, R. M., & Bullmore, E. T. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.16 · Cited by 1,662

Decreased Dendritic Spine Density on Prefrontal Cortical Pyramidal Neurons in Schizophrenia

Glantz, L. A., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.65 · Cited by 1,636

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

Geyer, M. A., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100811 · Cited by 1,484

Dendritic spine changes associated with hippocampal long-term synaptic plasticity

Engert, F., & Bonhoeffer, T. (1999) · Nature · doi:10.1038/19978 · Cited by 1,412

Dendritic spine pathology in neuropsychiatric disorders

Penzes, P., Cahill, M. E., Jones, K. A., VanLeeuwen, J.-E., & Woolfrey, K. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2741 · Cited by 1,523

Prenatal Infection and Schizophrenia: A Review of Epidemiologic and Translational Studies

Brown, A. S., & Derkits, E. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030361 · Cited by 1,269

Interneuron dysfunction in psychiatric disorders

Marín, O. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3155 · Cited by 1,190

Neuregulin-ERBB Signaling in the Nervous System and Neuropsychiatric Diseases

Mei, L., & Nave, K. (2014) · Neuron · doi:10.1016/j.neuron.2014.06.007 · Cited by 616

Common Mechanisms of Excitatory and Inhibitory Imbalance in Schizophrenia and Autism Spectrum Disorders

Gao, R., & Penzes, P. (2015) · Current Molecular Medicine · doi:10.2174/1566524015666150303003028 · Cited by 516

Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction

Ayalew, M., Le-Niculescu, H., Levey, D. F., Jain, N., Changala, B., Patel, S. D., Winiger, E. A., Breier, A. F., Shekhar, A., AMDUR, R. L., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.37 · Cited by 390

Differential Targeting of the CA1 Subfield of the Hippocampal Formation by Schizophrenia and Related Psychotic Disorders

Schobel, S., Lewandowski, N., Corcoran, C., Moore, H., Brown, T., Malaspina, D., & Small, S. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.115 · Cited by 384

Modeling the Positive Symptoms of Schizophrenia in Genetically Modified Mice: Pharmacology and Methodology Aspects

van den Buuse, M. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp132 · Cited by 352

An Overview of Animal Models Related to Schizophrenia

Winship, I. R., Dursun, S. M., Baker, G. B., Balista, P. A., Kandratavicius, L., Maia‐de‐Oliveira, J. P., Hallak, J. E. C., & Howland, J. G. (2018) · The Canadian Journal of Psychiatry · doi:10.1177/0706743718773728 · Cited by 263

ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation

Chen, Y., Zhang, M., Yin, D., Wen, L., Ting, A. K. L., Wang, P., Lu, Y.-S., Zhu, X.-H., Li, S.-J., Wu, C.-Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010669107 · Cited by 241

Selective Expression of ErbB4 in Interneurons, But Not Pyramidal Cells, of the Rodent Hippocampus

Vullhorst, D., Neddens, J., Karavanova, I. D., Tricoire, L., Petralia, R. S., McBain, C. J., & Buonanno, A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2454-09.2009 · Cited by 225

Prepulse inhibition and genetic mouse models of schizophrenia

Powell, S. B., Zhou, X., & Geyer, M. A. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.04.021 · Cited by 218

Cortical interneuron development: a tale of time and space

Hu, J. S., Vogt, D., Sandberg, M., & Rubenstein, J. L. (2017) · Development · doi:10.1242/dev.132852 · Cited by 189

Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap

Pratt, J. A., Winchester, C. L., Dawson, N., & MORRIS, B. J. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3649 · Cited by 199

Glutamatergic Synaptic Dysregulation in Schizophrenia: Therapeutic Implications

Coyle, J. T., Basu, A., Benneyworth, M., Balu, D., & Konopaske, G. (2012) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-25758-2_10 · Cited by 180

Signaling pathways in schizophrenia: emerging targets and therapeutic strategies

Karam, C. S., Ballon, J. S., Bivens, N. M., Freyberg, Z., Girgis, R. R., Lizardi-Ortiz, J. E., Markx, S., Lieberman, J. A., & Javitch, J. A. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.05.004 · Cited by 180

The Importance of the NRG-1/ErbB4 Pathway for Synaptic Plasticity and Behaviors Associated with Psychiatric Disorders

Shamir, A., Kwon, O., Karavanova, I. D., Vullhorst, D., Leiva‐Salcedo, E., Janssen, M. J., & Buonanno, A. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1899-11.2012 · Cited by 176

The neuregulin signaling pathway and schizophrenia: From genes to synapses and neural circuits

Buonanno, A. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.07.012 · Cited by 173

Schizophrenia susceptibility pathway neuregulin 1–ErbB4 suppresses Src upregulation of NMDA receptors

Pitcher, G. M., Kalia, L. V., Ng, D., Goodfellow, N. M., Yee, K. T., Lambe, E. K., & Salter, M. W. (2011) · Nature Medicine · doi:10.1038/nm.2315 · Cited by 164

NMDAR Hypofunction Animal Models of Schizophrenia

Lee, G. S., & Zhou, Y. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00185 · Cited by 168

Beyond cAMP: the regulation of Akt and GSK3 by dopamine receptors

Beaulieu, J. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00038 · Cited by 165

Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy

Law, A. J., Wang, Y., Sei, Y., O’Donnell, P., Piantadosi, P., Papaleo, F., Straub, R. E., Huang, W., Thomas, C. J., Vakkalanka, R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206118109 · Cited by 147

ErbB receptors and the development of the nervous system

Birchmeier, C. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.10.035 · Cited by 140

Reversal of Behavioral Deficits and Synaptic Dysfunction in Mice Overexpressing Neuregulin 1

Yin, D., Chen, Y., Lu, Y.-S., Bean, J. C., Sathyamurthy, A., Shen, C., Liu, X., Lin, T. W., Smith, C. A., Xiong, W., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.03.028 · Cited by 144

Modeling cognitive endophenotypes of schizophrenia in mice

Kellendonk, C., Simpson, E. H., & Kandel, E. R. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.02.003 · Cited by 136

Review of Pathological Hallmarks of Schizophrenia: Comparison of Genetic Models With Patients and Nongenetic Models

Jaaro-Peled, H., Ayhan, Y., Pletnikov, M. V., & Sawa, A. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp133 · Cited by 144

Neuregulin 1 transgenic mice display reduced mismatch negativity, contextual fear conditioning and social interactions

Ehrlichman, R. S., Luminais, S. N., White, S., Rudnick, N. D., Ma, N., Dow, H. C., Kreibich, A. S., Abel, T. G., Brodkin, E. S., Hahn, C.-G., et al. (2009) · Brain Research · doi:10.1016/j.brainres.2009.07.065 · Cited by 134

Developmental vulnerability of synapses and circuits associated with neuropsychiatric disorders

Penzes, P., Buonanno, A., Passafaro, M., Sala, C., & Sweet, R. A. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12261 · Cited by 125

Genetic Models of Sensorimotor Gating: Relevance to Neuropsychiatric Disorders

Powell, S. B., Weber, M., & Geyer, M. A. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_195 · Cited by 127

Impaired long-term memory retention and working memory in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia

Takao, K., Toyama, K., Nakanishi, K., Hattori, S., Takamura, H., Takeda, M., Miyakawa, T., & Hashimoto, R. (2008) · Molecular Brain · doi:10.1186/1756-6606-1-11 · Cited by 126

Transient exposure of neonatal mice to neuregulin-1 results in hyperdopaminergic states in adulthood: implication in neurodevelopmental hypothesis for schizophrenia

Kato, T., Abe, Y., Sotoyama, H., Kakita, A., Kominami, R., Hirokawa, S., Ozaki, M., Takahashi, H., & Nawa, H. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.10 · Cited by 110

Phenotypic Characterization of Transgenic Mice Overexpressing Neuregulin-1

Kato, T., Kasai, A., Mizuno, M., Fengyi, L., Shintani, N., Maeda, S., Yokoyama, M., Ozaki, M., & Nawa, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014185 · Cited by 114

Molecular Mechanism for Age-Related Memory Loss: The Histone-Binding Protein RbAp48

Pavlopoulos, E., Jones, S., Kosmidis, S., Close, M., Kim, C., Kovalerchik, O., Small, S. A., & Kandel, E. R. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006373 · Cited by 109

Arachidonic Acid Drives Postnatal Neurogenesis and Elicits a Beneficial Effect on Prepulse Inhibition, a Biological Trait of Psychiatric Illnesses

Maekawa, M., Takashima, N., Matsumata, M., Ikegami, S., Kontani, M., Hara, Y., Kawashima, H., Owada, Y., Kiso, Y., Yoshikawa, T., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005085 · Cited by 109

Dysregulated Expression of Neuregulin-1 by Cortical Pyramidal Neurons Disrupts Synaptic Plasticity

Agarwal, A., Zhang, M., Trembak-Duff, I., Unterbarnscheidt, T., Radyushkin, K., Dibaj, P., Martins‐de‐Souza, D., Boretius, S., Brzózka, M. M., Steffens, H., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.026 · Cited by 108

Mouse models of genetic effects on cognition: Relevance to schizophrenia

Papaleo, F., Lipska, B. K., & Weinberger, D. R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.025 · Cited by 107

Schizophrenia is associated with dysregulation of a Cdk5 activator that regulates synaptic protein expression and cognition

Engmann, O., Hortobágyi, T., Pidsley, R., Troakes, C., Bernstein, H., Kreutz, M. R., Mill, J. S., Nikolić, M., & Giese, K.-P. (2011) · Brain · doi:10.1093/brain/awr155 · Cited by 108

Synaptic plasticity, neural circuits, and the emerging role of altered short-term information processing in schizophrenia

Crabtree, G. W., & Gogos, J. A. (2014) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2014.00028 · Cited by 106

Losing your inhibition: Linking cortical GABAergic interneurons to schizophrenia

Inan, M., Petros, T. J., & Anderson, S. A. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.11.013 · Cited by 105

Animal Models of Schizophrenia

Young, J. W., Zhou, X., & Geyer, M. A. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_62 · Cited by 97

Neuregulin 1 hypomorphic mutant mice: enhanced baseline locomotor activity but normal psychotropic drug-induced hyperlocomotion and prepulse inhibition regulation

van den Buuse, M., Wischhof, L., Lee, R. X., Martin, S., & Karl, T. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000388 · Cited by 97

Neuregulin signaling, cortical circuitry development and schizophrenia

Rico, B., & Marín, Ó. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.12.010 · Cited by 92

Disturbed macro-connectivity in schizophrenia linked to oligodendrocyte dysfunction: from structural findings to molecules

Cassoli, J. S., Guest, P. C., Malchow, B., Schmitt, A., Falkai, P., & Martins‐de‐Souza, D. (2015) · Schizophrenia · doi:10.1038/npjschz.2015.34 · Cited by 91

Cognition in Mouse Models of Schizophrenia Susceptibility Genes

Arguello, P. A., & Gogos, J. A. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp153 · Cited by 86

Neuronal migration abnormalities and its possible implications for schizophrenia

Muraki, K., & Tanigaki, K. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00074 · Cited by 92

Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models

Samsom, J., & Wong, A. H. C. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00013 · Cited by 88

Neuregulin-1 and schizophrenia in the genome-wide association study era

Mostaid, M. S., Lloyd, D., Liberg, B., Sundram, S., Pereira, A. M., Pantelis, C., Karl, T., Weickert, C. S., Everall, I., & Bousman, C. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.001 · Cited by 82

Transgenic Overexpression of the Type I Isoform of Neuregulin 1 Affects Working Memory and Hippocampal Oscillations but not Long-term Potentiation

Deakin, I. H., Nissen, W., Law, A. J., Lane, T. A., Kanso, R., Schwab, M. H., Nave, K., Lamsa, K. P., Paulsen, O., Bannerman, D. M., et al. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhr223 · Cited by 81

Neuregulin‐1 positively modulates glial response and improves neurological recovery following traumatic spinal cord injury

Alizadeh, A., Dyck, S. M., Kataria, H., Shahriary, G. M., Nguyen, D. H., Santhosh, K. T., & Karimi‐Abdolrezaee, S. (2017) · Glia · doi:10.1002/glia.23150 · Cited by 80

Neuregulin 1–erbB4 pathway in schizophrenia: From genes to an interactome

Banerjee, A., MacDonald, M. L., Borgmann‐Winter, K. E., & Hahn, C.-G. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.04.011 · Cited by 82

Gene models of schizophrenia: DISC1 mouse models

Jaaro-Peled, H. (2009) · Progress in brain research · doi:10.1016/s0079-6123(09)17909-8 · Cited by 83

Neural circuit dysfunction in schizophrenia: Insights from animal models

Sigurdsson, T. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.059 · Cited by 77

Intramembranous Valine Linked to Schizophrenia Is Required for Neuregulin 1 Regulation of the Morphological Development of Cortical Neurons

Chen, Y., Hancock, M., Role, L. W., & Talmage, D. A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0605-10.2010 · Cited by 76

Schizophrenia‐related endophenotypes in heterozygous neuregulin‐1 ‘knockout’ mice

O’Tuathaigh, C. M. P., Harte, M., O’Leary, C., O'Sullivan, G., Blau, C., Lai, D., Harvey, R. P., Tighe, O., Fagan, A. J., Kerskens, C., et al. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07069.x · Cited by 76

Mutant Mouse Models: Genotype-Phenotype Relationships to Negative Symptoms in Schizophrenia

O’Tuathaigh, C. M. P., Kirby, B. P., Moran, P. M., & Waddington, J. L. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp125 · Cited by 73

Mice with genetically altered glutamate receptors as models of schizophrenia: A comprehensive review

Inta, D., Monyer, H., Sprengel, R., Meyer‐Lindenberg, A., & Gass, P. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.010 · Cited by 67

Phenotypic effects of maternal immune activation and early postnatal milieu in mice mutant for the schizophrenia risk gene neuregulin-1

O’Leary, C., Desbonnet, L., Clarke, N. E., Petit, E., Tighe, O., Lai, D., Harvey, R. P., Waddington, J. L., & O’Tuathaigh, C. M. P. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.06.028 · Cited by 66

Neurodevelopmental Animal Models of Schizophrenia: Role in Novel Drug Discovery and Development

Wilson, C., & Terry, A. V. (2010) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.4.2.4 · Cited by 70

Schizophrenia: Treatment Targets Beyond Monoamine Systems

Ibrahim, H. M., & Tamminga, C. A. (2011) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105851 · Cited by 63

Neuregulin-1 attenuates cognitive function impairments in a transgenic mouse model of Alzheimer’s disease

Ryu, J., Hong, B.-H., Kim, Y., Yang, E.-J., Choi, M., Kim, H., Ahn, S., Baik, T.-K., Woo, R.-S., & Hs, K. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.30 · Cited by 64

Neuregulin 1: an intriguing therapeutic target for neurodevelopmental disorders

Shi, L., & Bergson, C. M. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00868-5 · Cited by 60

ErbB4 signaling in dopaminergic axonal projections increases extracellular dopamine levels and regulates spatial/working memory behaviors

Skirzewski, M., Karavanova, I. D., Shamir, A., Erben, L., García‐Olivares, J., Shin, J. H., Vullhorst, D., Alvarez, V. A., Amara, S., & Buonanno, A. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.132 · Cited by 62

Neuregulin-1 signalling and antipsychotic treatment

Deng, C., Pan, B., Engel, M., & Huang, X. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3003-2 · Cited by 59

Do transmembrane domain neuregulin 1 mutant mice exhibit a reliable sensorimotor gating deficit?

Karl, T., Burne, T. H. J., van den Buuse, M., & Chesworth, R. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.04.051 · Cited by 59

Mice mutant for genes associated with schizophrenia: Common phenotype or distinct endophenotypes?

Desbonnet, L., Waddington, J. L., & O’Tuathaigh, C. M. P. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.04.001 · Cited by 57

Neuregulin-2 ablation results in dopamine dysregulation and severe behavioral phenotypes relevant to psychiatric disorders

Yan, L.-Q., Shamir, A., Skirzewski, M., Leiva‐Salcedo, E., Kwon, O., Karavanova, I. D., Paredes, D., Malkesman, O., Bailey, K. R., Vullhorst, D., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.22 · Cited by 59

A negative feedback loop controls NMDA receptor function in cortical interneurons via neuregulin 2/ErbB4 signalling

Vullhorst, D., Mitchell, R. M., Keating, C. E., Roychowdhury, S., Karavanova, I. D., Tao-Cheng, J.-H., & Buonanno, A. (2015) · Nature Communications · doi:10.1038/ncomms8222 · Cited by 58

Cognition in female transmembrane domain neuregulin 1 mutant mice

Chesworth, R., Downey, L. E., Logge, W., Killcross, S., & Karl, T. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.09.019 · Cited by 58

Mutant models for genes associated with schizophrenia

Desbonnet, L., Waddington, J. L., & O’Tuathaigh, C. M. P. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370308 · Cited by 57

Srgap3 –/– mice present a neurodevelopmental disorder with schizophrenia‐related intermediate phenotypes

Waltereit, R., Leimer, U., Halbach, O. V. B. U., Panke, J., Hölter, S. M., Garrett, L., Wittig, K., Schneider, M., Schmitt, C., Calzada‐Wack, J., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-202317 · Cited by 55

Reciprocal signalling between NR2 subunits of the NMDA receptor and neuregulin1 and their role in schizophrenia

Geddes, A. E., Huang, X., & Newell, K. A. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.02.017 · Cited by 52

Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence

Turner, J. R., Ray, R., Lee, B., Everett, L. J., Xiang, J. J., Jepson, C., Kaestner, K. H., Lerman, C. E., & Blendy, J. A. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.104 · Cited by 49

Gene × Environment Interactions in Schizophrenia: Evidence from Genetic Mouse Models

Moran, P. M., Stokes, J., Marr, J., Bock, G., Desbonnet, L., Waddington, J. L., & O’Tuathaigh, C. M. P. (2016) · Neural Plasticity · doi:10.1155/2016/2173748 · Cited by 55

Genetic recovery of ErbB4 in adulthood partially restores brain functions in null mice

Wang, H., Liu, F., Chen, W., Sun, X., Cui, W., Dong, Z., Zhao, K., Zhang, H., Li, H., Xing, G., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1811287115 · Cited by 45

A 5′ promoter region SNP in NRG1 is associated with schizophrenia risk and type III isoform expression

Nicodemus, K. K., Law, A. J., Luna, A., Vakkalanka, R., Straub, R. E., Kleinman, J. E., & Weinberger, D. R. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.150 · Cited by 42

Mice lacking the kf-1 gene exhibit increased anxiety- but not despair-like behavior

Tsujimura, A. (2008) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.004.2008 · Cited by 43

Transient Overexposure of Neuregulin 3 during Early Postnatal Development Impacts Selective Behaviors in Adulthood

Paterson, C., & Law, A. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104172 · Cited by 38

Meta-analysis reveals associations between genetic variation in the 5′ and 3′ regions of Neuregulin-1 and schizophrenia

Mostaid, M. S., Mancuso, S. G., Liu, C., Sundram, S., Pantelis, C., Everall, I., & Bousman, C. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.279 · Cited by 42

Do COMT, BDNF and NRG1 polymorphisms influence P50 sensory gating in psychosis?

Shaikh, M., Hall, M., Schulze, K., Dutt, A., Walshe, M., Williams, I. L., Constante, M., Picchioni, M., Toulopoulou, T., Collier, D. A., et al. (2010) · Psychological Medicine · doi:10.1017/s003329170999239x · Cited by 40

Perinatal phencyclidine treatment alters neuregulin 1/erbB4 expression and activation in later life

du Bois, T. M., Newell, K. A., & Huang, X. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.09.002 · Cited by 39

Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis

Bousman, C. A., Yung, A. R., Pantelis, C., Ellis, J. A., Chavez, R. A., Nelson, B., Lin, A., Wood, S. J., Amminger, G. P., Velakoulis, D., et al. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.23 · Cited by 38

Neuregulin1 signaling promotes dendritic spine growth through kalirin

Cahill, M. E., Remmers, C. L., Jones, K. A., Xie, Z., Sweet, R. A., & Penzes, P. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12330 · Cited by 40

Type III Neuregulin 1 Is Required for Multiple Forms of Excitatory Synaptic Plasticity of Mouse Cortico-Amygdala Circuits

Jiang, L., Emmetsberger, J., Talmage, D. A., & Role, L. W. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2888-12.2013 · Cited by 37

Animal models of schizophrenia for molecular and pharmacological intervention and potential candidate molecules

Mouri, A., Nagai, T., Ibi, D., & Yamada, K. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.10.025 · Cited by 38

Microglia-derived neuregulin expression in psychiatric disorders

Ikawa, D., Makinodan, M., Iwata, K., Ohgidani, M., Kato, T. A., Yamashita, Y., Yamamuro, K., Kimoto, S., Toritsuka, M., Yamauchi, T., et al. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.01.003 · Cited by 40

Spine impairment in mice high-expressing neuregulin 1 due to LIMK1 activation

Chen, P., Jing, H., Xiong, M., Zhang, Q., Dong, L., Ren, D., Wang, S., Yin, D., Chen, Y., Zhou, T. G., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03687-8 · Cited by 37

Novel molecular changes induced by Nrg1 hypomorphism and Nrg1-cannabinoid interaction in adolescence: a hippocampal proteomic study in mice

Spencer, J. R., Darbyshire, K. M. E., Boucher, A. A., Kashem, M. A., Long, L. E., McGregor, I. S., Karl, T., & Arnold, J. C. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00015 · Cited by 35

Chronic nicotine improves short‐term memory selectively in a G 72 mouse model of schizophrenia

Hambsch, B., Keyworth, H. L., Lind, J., Otte, D. M., Rácz, I., Kitchen, I., Bailey, A., & Zimmer, A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12578 · Cited by 36

Advancing a functional genomics for schizophrenia: Psychopathological and cognitive phenotypes in mutants with gene disruption

Kirby, B. P., Waddington, J. L., & O’Tuathaigh, C. M. P. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.09.010 · Cited by 36

An alternative splicing hypothesis for neuropathology of schizophrenia: evidence from studies on historical candidate genes and multi-omics data

Zhang, C., Xiao, X., Zhang, Z., Hu, Z., & Li, M. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01037-w · Cited by 33

Neonatal infection with neurotropic influenza A virus affects working memory and expression of type III Nrg1 in adult mice

Asp, L., Beraki, S., Kristensson, K., Ögren, S. O., & Karlsson, H. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.04.004 · Cited by 33

Overexpression of Neuregulin 1 Type III Confers Hippocampal mRNA Alterations and Schizophrenia-Like Behaviors in Mice

Olaya, J. C., Heusner, C. L., Matsumoto, M., Sinclair, D., Kondo, M., Karl, T., & Weickert, C. S. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx122 · Cited by 36

Neuregulin 1 Prevents Phencyclidine-Induced Behavioral Impairments and Disruptions to GABAergic Signaling in Mice

Engel, M., Snikeris, P., Jenner, A. M., Karl, T., Huang, X., & Frank, E. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu114 · Cited by 32

Cell autonomous regulation of hippocampal circuitry via Aph1b-γ-secretase/neuregulin 1 signalling

Fazzari, P., Snellinx, A., Sabanov, V., Ahmed, T., Serneels, L., Gärtner, A., Shariati, S. A., Balschun, D., & Strooper, B. D. (2014) · eLife · doi:10.7554/elife.02196 · Cited by 33

Partial Genetic Deletion of Neuregulin 1 Modulates the Effects of Stress on Sensorimotor Gating, Dendritic Morphology, and HPA Axis Activity in Adolescent Mice

Chohan, T. W., Boucher, A. A., Spencer, J. R., Kassem, M. S., Hamdi, A. A., Karl, T., Fok, S., Bennett, M. R., & Arnold, J. C. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt193 · Cited by 31

An essential role for neuregulin-4 in the growth and elaboration of developing neocortical pyramidal dendrites

Páramo, B., Wyatt, S. L., & Davies, A. M. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.01.002 · Cited by 30

Environmental Enrichment Induces Epigenomic and Genome Organization Changes Relevant for Cognition

Espeso‐Gil, S., Holik, A. Z., Bonnin, S., Jhanwar, S., Chandrasekaran, S., Piqué-Regi, R., Albaigès, J., Maher, M., Permanyer, J., Irimia, M., et al. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.664912 · Cited by 28

Targeted deletion of the C-terminus of the mouse adenomatous polyposis coli tumor suppressor results in neurologic phenotypes related to schizophrenia

Onouchi, T., Kobayashi, K., Sakai, K., Shimomura, A., Smits, R., Sumi‐Ichinose, C., Kurosumi, M., Takao, K., Nomura, R., Iizuka‐Kogo, A., et al. (2014) · Molecular Brain · doi:10.1186/1756-6606-7-21 · Cited by 30

Neuregulin 1 Type I Overexpression Is Associated with Reduced NMDA Receptor–Mediated Synaptic Signaling in Hippocampal Interneurons Expressing PV or CCK

Kotzadimitriou, D., Nissen, W., Paizs, M., Newton, K., Harrison, P. J., Paulsen, O., & Lamsa, K. P. (2018) · eNeuro · doi:10.1523/eneuro.0418-17.2018 · Cited by 30

Risk genes for schizophrenia: Translational opportunities for drug discovery

Winchester, C. L., Pratt, J. A., & MORRIS, B. J. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.003 · Cited by 32

Disrupted Activity in the Hippocampal–Accumbens Circuit of Type III Neuregulin 1 Mutant Mice

Nason, M. W., Adhikari, A., Bozinoski, M., Gordon, J. A., & Role, L. W. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.180 · Cited by 28

Cerebral doi:10.1093/cercor/bhr223 Transgenic Overexpression of the Type I Isoform of Neuregulin 1 Affects Working Memory and Hippocampal Oscillations but not Long-term Potentiation

Deakin, I. H., Nissen, W., Law, A. J., Lane, T. A., Kanso, R., Schwab, M. H., Nave, K., Lamsa, K. P., Paulsen, O., Bannerman, D. M., et al. (2016)

Transgenic Overexpression of the Type I Isoform of Neuregulin 1 Affects Working Memory and Hippocampal Oscillations but not Long-term Potentiation

Deakin, I. H., Nissen, W., Law, A. J., Lane, T. A., Kanso, R., Schwab, M. H., Nave, K., Lamsa, K. P., Paulsen, O., Bannerman, D. M., et al. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhr223 · Cited by 81

Deregulated NLRP3 inflammasome response due to a constitutive activation of NF-κB p65 pro-inflammatory pathway in lymphomonocytes of Rett syndrome patients

Cordone, V., Vallese, A., Pecorelli, A., Guiotto, A., Ferrara, F., Benedusi, M., Cervellati, F., Hayek, J., & Valacchi, G. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.12.075

Neurobiological investigation of the Neuregulin 1 gene and Neuregulin 1 type III overexpression in the pathophysiology of schizophrenia

Olaya, J. C. (2019) · UNSWorks (University of New South Wales, Sydney, Australia) · doi:10.26190/unsworks/3703